Ingredient or product comparison
Clinical Evidence Comparing GHK-Cu vs Hyaluronic Acid Skin Rejuvenation
A double-blind study published in Clinical, Cosmetic and Investigational Dermatology (2015) evaluated topical GHK-Cu cream (3% concentration) against vehicle control over 12 weeks in 67 participants aged 50–65. Profilometry measurements showed statistically si
This source-based comparison does not add ratings or recommend a winner.
- A double-blind study published in Clinical, Cosmetic and Investigational Dermatology (2015) evaluated topical GHK-Cu cream (3% concentration) against vehicle control over 12 weeks in 67 participants aged 50–65. Profilometry measurements showed statistically significant reduction in wrinkle depth (mean 31.2% improvement vs 2.1% placebo, p<0.001), alongside increased skin density measured by ultrasound elastography. Biopsy samples analyzed via immunohistochemistry revealed increased dermal collagen density and reduced elastin fragmentation in treated skin.
- For hyaluronic acid, a 2014 randomized controlled trial in Journal of Clinical and Aesthetic Dermatology tested topical application of 0.1% low-molecular-weight HA versus placebo in 76 subjects over eight weeks. Skin hydration measured by corneometry increased 96% from baseline in the HA group versus 11% in controls. But when measurements were taken 72 hours after discontinuing application, the difference vanished entirely (p=0.89). Profilometry showed no significant change in wrinkle depth or dermal thickness at any timepoint.
- The evidence pattern is consistent across multiple trials: GHK-Cu produces cumulative structural changes that persist after treatment ends, while hyaluronic acid delivers temporary hydration benefits that require continuous application. Neither compound showed significant adverse events in clinical trials at standard concentrations (GHK-Cu ≤5%, HA ≤2%), though copper-peptide formulations occasionally trigger mild erythema in sensitive skin during the first week of use.